29 million people in the EU suffer from liver disease. Liver disease includes a range of diseases and symptoms, most of which have a significant inflammatory component that leads to liver damage. There are currently no therapies targeting the inflammatory aspects of liver disease.
An insight into research being undertaken by the National Institute for Health Research Birmingham Liver Biomedical Research Unit at the University of Birmingham and Queen Elizabeth Hospital.
Join Professor Janet Lord (Head of School of Immunity and Infection, College of Medical and Dental Sciences) as she describes her career to date, her passion for her research and how it is helping to change the world, and how she enjoys working with postgraduate researchers from the UK and abroad.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.